Juvenile Diabetes Research Foundation:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Juvenile Diabetes Research Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9270
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Juvenile Diabetes Research Foundation (JDRF) is a research organization that offers funding services for type 1 diabetes. The organization conducts clinical trials for curing, preventing and treating for type 1 diabetes and its complications; and researching new drugs for patients to manage diabetes. It also performs clinical trials and tolerance assay studies in transplantation, autoimmune diseases, and allergy and asthma. JDRF provides diabetes clinical trials to laboratories, educational institutions, and pharmaceutical and medical research companies. The organization has operations in Australia, Canada, Denmark, Israel, Netherlands and the UK. It partners with pharmaceuticals, healthcare and automobile companies to eradicate type 1 diabetes. JDRF is headquartered in New York, the US.

Juvenile Diabetes Research Foundation – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Juvenile Diabetes Research Foundation, Medical Devices Deals, 2012 to YTD 2018 10
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
T1D Innovations Raises US$5 Million In Venture Financing 13
Partnerships 14
Juvenile Diabetes and Gubra Enter into Partnership Agreement 14
Biocon Enters into Agreement with Juvenile Diabetes Research Foundation 15
vTv Therapeutics Enters into Agreement with Juvenile Diabetes Research Foundation 16
JDRF Enters into Agreement with Pacific Diabetes Technologies 17
Diamyd Medical Enter into Partnership with Janssen R&D, JDRF and UAB 18
MannKind Partners with JDRF 19
Sanofi and Juvenile Diabetes Research Foundation Partner with Four Research Organizations 20
Regimmune Enters into Research Agreement with JDRF and Pfizer 22
European Foundation for the Study of Diabetes, JDRF and Eli Lilly Extends Research Agreement 23
Selecta Biosciences and Juvenile Diabetes Research Foundation Enter into Co-Development Agreement with Sanofi 24
Juvenile Diabetes Research Partners with Xeris Pharma and LATITUDE Pharma 25
Novo Nordisk Enters Into R&D Agreement With Juvenile Diabetes Research Foundation For Type 1 Diabetes 26
KalVista Pharma Enters Into Research Agreement With JDRF 27
Equity Offering 28
Bigfoot Biomedical Raises Funds in Equity Financing 28
AnTolRx to Raise USD4 Million in Private Placement of Shares 29
Sernova to Raise USD2.5 Million in Private Placement of Shares 30
Juvenile Diabetes Research Foundation – Key Competitors 31
Juvenile Diabetes Research Foundation – Key Employees 32
Juvenile Diabetes Research Foundation – Locations And Subsidiaries 34
Head Office 34
Recent Developments 35
Government and Public Interest 35
May 03, 2018: JDRF Awards International Diabetes Center Grant to Investigate the Use of Intranasal Insulin Delivery 35
Apr 10, 2018: JDRF, ADA and Helmsley Charitable Trust Issue Request for Proposals to Research Consistency and Potency of Insulin Purchased in U.S. Pharmacies 36
Mar 08, 2018: Unique inflammation patterns emerging in patients with type 1 diabetes 37
Feb 22, 2018: Frequency Therapeutics Awarded Grant from JDRF to Generate Glucose-Responsive Insulin-Secreting Cells for Type 1 Diabetes Treatment Using a Small Molecule Approach 38
Jan 04, 2018: Gene therapy restores normal blood glucose levels in mice with type 1 diabetes 39
Aug 31, 2017: Role of gut bacteria in averting Type 1 diabetes 40
Aug 01, 2017: Case Western Reserve University: Missing Signals Leads to Diabetic Nerve Injury 42
Mar 20, 2017: New Research Identifies Novel Target for Controlling Immune Response to Implanted Materials 43
Feb 27, 2017: City of Hope Researchers Discover New Potential Cause of Type 1 Diabetes 44
Feb 07, 2017: JDRF & Lilly Canada fund UBC research that could allow people with type 1 diabetes to produce their own insulin 46
Jan 12, 2017: JDRF Encouraged by Medicare Decision to Take First Step Toward Coverage of Continuous Glucose Monitors for People with Type 1 Diabetes 47
Product News 48
Jul 09, 2018: Human clinical trial reveals verapamil as an effective Type 1 diabetes therapy 48
Other Significant Developments 50
May 01, 2018: JDRF participates in new Research Project Hypo-RESOLVE to investigate Hypoglycaemia and its Impact in Diabetes 50
Feb 15, 2018: JDRF and The Mary Tyler Moore & S. Robert Levine, MD Charitable Foundation Launch Research Moonshot to Restore Vision in People with Diabetes-Related Eye Disease 51
Jan 09, 2018: JDRF Research Accomplishments Lead the Way to Prevent Future Type 1 Diabetes Diagnoses 53
Dec 01, 2017: JDRF Launches Health Insurance Guide to Help People with Type 1 Diabetes Navigate Common Insurance Challenges 55
Appendix 56
Methodology 56
About GlobalData 56
Contact Us 56
Disclaimer 56

List of Tables
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Key Facts 2
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Juvenile Diabetes Research Foundation, Deals By Therapy Area, 2012 to YTD 2018 9
Juvenile Diabetes Research Foundation, Medical Devices Deals, 2012 to YTD 2018 10
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
T1D Innovations Raises US$5 Million In Venture Financing 13
Juvenile Diabetes and Gubra Enter into Partnership Agreement 14
Biocon Enters into Agreement with Juvenile Diabetes Research Foundation 15
vTv Therapeutics Enters into Agreement with Juvenile Diabetes Research Foundation 16
JDRF Enters into Agreement with Pacific Diabetes Technologies 17
Diamyd Medical Enter into Partnership with Janssen R&D, JDRF and UAB 18
MannKind Partners with JDRF 19
Sanofi and Juvenile Diabetes Research Foundation Partner with Four Research Organizations 20
Regimmune Enters into Research Agreement with JDRF and Pfizer 22
European Foundation for the Study of Diabetes, JDRF and Eli Lilly Extends Research Agreement 23
Selecta Biosciences and Juvenile Diabetes Research Foundation Enter into Co-Development Agreement with Sanofi 24
Juvenile Diabetes Research Partners with Xeris Pharma and LATITUDE Pharma 25
Novo Nordisk Enters Into R&D Agreement With Juvenile Diabetes Research Foundation For Type 1 Diabetes 26
KalVista Pharma Enters Into Research Agreement With JDRF 27
Bigfoot Biomedical Raises Funds in Equity Financing 28
AnTolRx to Raise USD4 Million in Private Placement of Shares 29
Sernova to Raise USD2.5 Million in Private Placement of Shares 30
Juvenile Diabetes Research Foundation, Key Competitors 31
Juvenile Diabetes Research Foundation, Key Employees 32

List of Figures
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Juvenile Diabetes Research Foundation, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Juvenile Diabetes Research Foundation:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Public Joint-Stock Company Commercial Bank Privatbank
    Public Joint-Stock Company Commercial Bank Privatbank - Strategy, SWOT and Corporate Finance Report Summary Public Joint-Stock Company Commercial Bank Privatbank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • Falck Renewables S.p.A. (FKR):企業の財務・戦略的SWOT分析
    Falck Renewables S.p.A. (FKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Egalet Corp (EGLT):製薬・医療:M&Aディール及び事業提携情報
    Summary Egalet Corp (Egalet) is a specialty pharmaceutical company that develops, manufactures and commercializes novel treatments for pain and other conditions. Its product portfolio includes OXAYDO (oxycodone HCl, USP) tablets CII for the management of acute and chronic moderate to severe pain; SP …
  • Hot Topic, Inc.:企業の戦略・SWOT・財務情報
    Hot Topic, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hot Topic, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Continental Engineering Corporation:企業の戦略・SWOT・財務分析
    Continental Engineering Corporation - Strategy, SWOT and Corporate Finance Report Summary Continental Engineering Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • AltaGas Ltd (ALA):企業の財務・戦略的SWOT分析
    AltaGas Ltd (ALA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Bloomsbury Publishing Plc (BMY):企業の財務・戦略的SWOT分析
    Bloomsbury Publishing Plc (BMY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Sejal Glass Limited (SEZAL):企業の財務・戦略的SWOT分析
    Sejal Glass Limited (SEZAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Kenya Power and Lighting Co Ltd (KPLA):企業の財務・戦略的SWOT分析
    Kenya Power and Lighting Co Ltd (KPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • S. Kumars Nationwide Limited:戦略・SWOT・企業財務分析
    S. Kumars Nationwide Limited - Strategy, SWOT and Corporate Finance Report Summary S. Kumars Nationwide Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Ashley Furniture Industries Inc:企業の戦略・SWOT・財務情報
    Ashley Furniture Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Ashley Furniture Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Polpharma SA:企業の戦略的SWOT分析
    Polpharma SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • SurModics Inc (SRDX)-医療機器分野:企業M&A・提携分析
    Summary SurModics Inc (SurModics) is a provider of device drug delivery coating and in vitro diagnostic technologies. The company offers wide range of advanced technologies that includes medical device coating technologies and surface modification coating technologies. Its technologies are employed …
  • EnergyAustralia Pty Ltd:電力:M&Aディール及び事業提携情報
    Summary EnergyAustralia Pty Ltd (EnergyAustralia), formerly TRUenergy, is an electric utility that invests in energy generation and retailing activities. The company generates electricity and retails power and gas. It produces electricity from coal, gas, solar and wind sources. EnergyAustralia offer …
  • SNC-Lavalin Group Inc.:企業の戦略・SWOT・財務情報
    SNC-Lavalin Group Inc. - Strategy, SWOT and Corporate Finance Report Summary SNC-Lavalin Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • PT Perusahaan Gas Negara (Persero) Tbk (PGAS):石油・ガス:M&Aディール及び事業提携情報
    Summary PT Perusahaan Gas Negara (Persero) Tbk (PGN) is a downstream energy that transmits and distributes natural gas. The company plans, constructs and develops downstream natural gas businesses and carries out processing, transportation, storage and trading of natural gas. It produces, trades and …
  • The British United Provident Association Ltd-製薬・医療分野:企業M&A・提携分析
    Summary The British United Provident Association Ltd (Bupa) is a leading global healthcare group. It offers health insurance and other funding products, chronic disease management services, home healthcare services, workplace health services and care services, comprising residential and nursing home …
  • The Nassau Companies of New York:企業の戦略的SWOT分析
    The Nassau Companies of New York - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Opiant Pharmaceuticals Inc (OPNT):医療機器:M&Aディール及び事業提携情報
    Summary Opiant Pharmaceuticals Inc (Opiant), formerly, Lightlake Therapeutics Inc is a specialty pharmaceutical company that develops pharmacological treatments for substance use, addiction and eating disorders. It focuses on developing treatments to reverse opioid overdoses, for overweight and obes …
  • Hemanext:製薬・医療:M&Aディール及び事業提携情報
    Summary Hemanext, formerly New Health Sciences Inc, is a medical technology company that develops blood storage systems. The company offers an anaerobic storage system that minimizes oxidative damage to red blood cells in storage and delivers physiologic, therapeutic, and fresher red blood cell than …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆